Press release
Estrogen Receptor Positive (ER+) Breast Cancer Industry Report and Analysis, 2017
MARKET RESEARCH HUB
Request for Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1009112
DelveInsights, Estrogen Receptor Positive (ER+) Breast Cancer - Treatment Landscape & Competitive Analysis, 2017, report provides comprehensive insights about the treatment landscape across this indication. This report also provides the deep understanding of the stages of the Estrogen Receptor Positive (ER+) Breast Cancer, epidemiology, risk factors, diagnosis etc. A key objective of the report is to establish the understanding of the treatment landscape and competitive analysis of the Estrogen Receptor Positive (ER+) Breast Cancer which mainly describes the treatment of breast cancer at different stages. Breast cancer is the condition where the cells of the breast area become tumorous, that is, they undergo unlimited cell division. Both women and men are affected but chances of men being diagnosed with breast cancer are rare. Each year about 2,300 new cases of breast cancer in men and about 230,000 new cases in women are diagnosed. It is the second most common cancer among women in USA.
Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1009112
This report provides the insights of the marketed drugs for the Estrogen Receptor Positive (ER+) Breast Cancer which includes the Targeted Therapy, Hormone Therapy and Chemotherapy. In case of Estrogen Receptor Positive (ER+) Breast Cancer, Hormone therapy is the main focus of treatment after surgery and chemotherapy. Hormonal therapy is usually recommended after 5 years of surgery and can be divided into Estrogen blocking hormonal therapy and estrogen lowering hormonal therapy based on the mechanism of action of the hormonal therapy drugs. Of all the late-stage pipeline drugs, Buparlisib is expected to reach the market in the next few years.
Recent report of DelveInsight covers the treatment landscape which provides the treatment options by different stages and type of the breast cancer. There are four chemotherapy drugs, six hormone therapy drugs and one targeted therapy drugs in market for the treatment of Estrogen Receptor Positive (ER+) Breast Cancer.
Note: This report will be delivered to the client in 1-2 business days
Browse Full Report with TOC: http://www.marketresearchhub.com/report/estrogen-receptor-positive-er-breast-cancer-treatment-landscape-and-competitive-analysis-2017-report.html
Report Highlights:
The new report, provides a Estrogen Receptor Positive (ER+) Breast Cancer Treatment Landscape across the globe
The report provides profiles of the marketed drug which includes the product description, cost of treatment, development partner, patent expiry date, sales data etc.
Comparative analysis of marketed drugs by therapy, cost of treatment, Therapeutic Class. Coverage of the Estrogen Receptor Positive (ER+) Breast Cancer Phase III and Pre-registration Drugs Analysis by product type, molecule type, route of administration, Median Progression Free Survival
The report reviews key players involved in the therapeutics development for Estrogen Receptor Positive (ER+) Breast Cancer and also provide market barriers, market drivers and opportunities
Provides Phase III products assessment by line of therapy and target.
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: www.marketresearchhub.com/
Follow Us on:
Twitter: twitter.com/MktResearchHub
LinkedIn: www.linkedin.com/company/market-research-hub
Facebook: www.facebook.com/MarketResearchHub
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Estrogen Receptor Positive (ER+) Breast Cancer Industry Report and Analysis, 2017 here
News-ID: 457747 • Views: …
More Releases from Industry Analysis Report - MRH
Global DC Motor Brush for Aircraft Market Research Report Revealing Key Drivers …
According to this report we, focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of DC Motor Brush for Aircraft for each application the “global DC Motor Brush for Aircraft market” is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Request…
Global Malt Whisky Market Anticipated to Grow at a Healthy Rate during the Forec …
The global malt whisky market is witnessing rapid growth over the past few years. Market research report predicts that the global single malt whiskey market will grow progressively due to the rising demand for premium single malt whiskey across the globe. The US and the UK will serve as the chief market for the increasing demand for these products. Considering this fact, a new market report with a title “Global…
Global Tocopherol Acetate Market to Expand at a Tremendous Rate during the Forec …
This market report is a highly detailed study of the global tocopherol acetate market. It offers a comprehensive overview of the various applications and end users of the market and how the demand and supply are anticipated to alter over the forthcoming years. Market Research Hub (MRH) has recently added a new market report to its vast online collection. This research report is titled as “Global Tocopherol Acetate Market” Research…
Global Astronomical Telescope Market Research Report : Share, Growth, Size, Tren …
The global Astronomical Telescope market is expected to grow at a steady rate and will post a healthy CAGR during the forecast period. The rising preference for minimally invasive (MI) procedures is likely to drive the growth prospects for the global industrial castings market over the coming years. A new market report with a title “Global Astronomical Telescope Market” Research Report 2017 has been recently added to the vast online…
More Releases for Estrogen
Estrogen Receptor Modulators Market Key Players, Share and Forecast Outlook
On April 29, 2025, Exactitude Consultancy., Ltd. released a research report titled "Estrogen Receptor Modulators Market". This report covers the global Estrogen Receptor Modulators market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.…
Estrogen Receptor Modulators Market Key Players, Share and Forecast Outlook
On April 25, 2025, Exactitude Consultancy., Ltd. released a research report titled "Estrogen Receptor Modulators Market". This report covers the global Estrogen Receptor Modulators market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country, product type, and application. It also forecasts the market size of automotive kick sensors based on market patterns from 2020 to 2034 and future market trends.…
Advancements In Breast Cancer Treatment With Combination Treatment Of Estrogen B …
What industry-specific factors are fueling the growth of the estrogen blockers market?
The increasing occurrences of breast cancer are predicted to stimulate the development of the estrogen blocker market in the future. Breast cancer starts in the breast tissue, predominantly impacting the milk ducts and lobules. It transpires when there's a mutation in the breast cells, causing them to proliferate uncontrollably and create tumors. This cancer type's prevalence is climbing as…
How Artificial Intelligence is Shaping the Estrogen and Progesterone Market
Estrogen and Progesterone Market Revenue was valued at USD XX Billion in 2024 and is estimated to reach USD YY Billion by 2033, growing at a CAGR of ZZ% from 2026 to 2033.
Estrogen and Progesterone Market Future Scope
The Estrogen and Progesterone Market was valued at approximately USD 11.5 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6.8% from 2023 to 2030. The…
Emerging Estrogen Blockers Market Trend 2025-2034: Advancements In Breast Cancer …
How Is the Estrogen Blockers Market Projected to Grow, and What Is Its Market Size?
The market size for estrogen blockers has seen considerable growth in the past few years. The market worth will catapult from $9.35 billion in 2024 to $10.05 billion in 2025 with a compounded annual growth rate (CAGR) of 7.5%. The exponential growth in the preceding period can be traced back to an escalation in the occurrence…
Conjugated Estrogen Market Size, Industry Status and Forecast 2018-2028
Conjugated estrogen is an active pharmaceutical ingredient that contains a mixture of steroidal and non-steroidal components that are obtained from pregnant mares’ urine. Conjugated estrogen is used as an external source and is prescribed as a replacement of female natural hormones. Estrogen has many well-known effects on the tissues of the body. It causes the growth of the inner lining of uterus, secretion of cervix, development & growth of female…
